'One of the most geometrically perfect': What is this mysterious sphere deep in the Milky Way galaxy?
When you buy through links on our articles, Future and its syndication partners may earn a commission.
There's no shortage of round celestial objects in our universe. Planets, moons and stars all exhibit lovely spherical shapes. But astronomers recently spotted a mysteriously circular orb deep in the Milky Way galaxy — and it's certainly none of these things.
This celestial bubble, discovered by astrophysicist Miroslav Filipović of Western Sydney University, is likely a supernova remnant (SNR), an expanding shell of gas and dust formed by shockwaves from a massive stellar explosion. SNRs aren't uncommon, but this particular example showcases numerous anomalies, including its astonishingly round shape. For that shape, Filipović and his team named SNR Teleios, the Greek word for "perfect."
Filipović discovered Teleios — officially designated G305.4–2.2 — by accident, scanning through new images taken by the radio telescope Australian Square Kilometre Array Pathfinder (ASKAP). ASKAP is currently surveying the entire southern hemisphere sky. "I was looking at these images as they became available, searching for anything interesting, or not seen before, and came across Teleios," Filipović told Space.com. "Its perfectly circular shape was unusual, and so I investigated further."
Using data from ASKAP and the Murchison Widefield Array, Filipović and his team estimate that Teleios spans either about 46 light-years across at a distance of about 7,175 light-years from Earth, or about 157 light-years across at a distance of about 25,114 light-years from Earth. (Judging such vast distances in space is difficult.) Regardless of the size and distance of Teleios, though, the SNR's near-perfect symmetry is extraordinary. Its shape was quantified with a circularity score of 95.4%, placing it among the most symmetric known SNRs.
While idealized models suggest SNRs remnants should be circular, reality often paints a more chaotic picture. "'Typical' SNR shapes vary dramatically, either from asymmetries in the initial explosion, or disruption from expanding into a non-perfect environment, or a number of other interfering factors," says Filipović. "What makes Teleios' shape so remarkable is that it displays none of these asymmetries; it effectively looks like an explosion that has happened with almost perfect initial parameters and with almost no disruption while expanding."
So, what could explain such an undisturbed evolution? According to Filipović, it likely comes down to location. Teleios lies 2.2 degrees below the Galactic Plane, where interstellar gas and dust are significantly more sparse. This environment may have allowed the remnant to expand while remaining largely undisturbed for thousands of years.
Teleios' shape is only one of the unusual characteristics of this SNR. Adding to the mystery, Teleios emits only in radio wavelengths, with a hint of hydrogen-alpha emissions. "Most SNRs are visible at another frequency. They either emit at optical, infrared, or X-ray frequencies as well," says Filipović. "The fact that we don't see that here is quite confusing. It could be that the temperatures are not high enough to produce this emission, or that Teleios is old enough that the optical emission has faded, but the radio emission is still present."
Related Stories:
— Hundreds of supernova remnants remain hidden in our galaxy. These astronomers want to find them— Mysterious cosmic lights turn out to be 2 undiscovered supernova remnants— Watch 2 gorgeous supernova remnants evolve over 20 years (timelapse video)
This lack of emissions poses challenges to determining the type of supernova that produced Teleios. The most likely scenario is a Type Ia supernova, which occurs in binary star systems in which a white dwarf consumes enough mass of its companion star to explode violently. Alternatively, Teleios' origin might be Type Iax supernova, which is similar to a Type Ia supernova but one that leaves behind a "zombie" star. But Teleios's observable data doesn't fit either model perfectly.
As it goes with newfound objects in the universe, researchers have a lot more to study to unravel all of Teleios's mysteries. Fortunately, there's no better time to study SNRs. "These are the 'golden days' for radio astronomy as the new instruments, such as ASKAP and MeerKAT, are opening windows for new discoveries," says Filipović.
A paper on the findings has been submitted to the Publications of the Astronomical Society of Australia, and is presently available on preprint server arXiv.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 hours ago
- Yahoo
Long-Dead NASA Satellite Suddenly Lets Out Epic Blast of Energy
NASA's experimental Relay 2 satellite had been dead in the sky since 1967 — until last summer, when it emitted a super-short and very powerful burst of energy out of nowhere. In an interview with New Scientist, one of the researchers from Australia's Curtin University who discovered the strange pulse coming off the dead communications satellite described his shock at finding the nearby source of that nanosecond-long energy blast. Curtin astronomer Clancy James and his team had been using the Australian Square Kilometer Array Pathfinder (ASKAP) radio telescope array when they detected something so "loud" that it briefly outshone everything else in the night sky. Even stranger, it turned out, the signal was coming from so close to Earth that ASKAP's radio telescopes couldn't all focus on it at once. "We got all excited, thinking maybe we'd discovered a new pulsar or some other object," James told New Scientist. "This was an incredibly powerful radio pulse that vastly outshone everything else in the sky for a very short amount of time." As explained in a new paper that's now awaiting peer review, the Curtin researchers eventually traced the source of the pulse to NASA's derelict Relay 2 — but that discovery raised more questions than answers. Because Relay 2 had been dead for nearly 60 years, the Curtin team thinks that something either collided with the defunct communications craft that made it produce such a wild racket, or that electricity had been building up within it for so long that it resulted in a huge type of energy burst known as an "electrostatic discharge." As astrophysicist Karen Aplin of the UK's University of Bristol told New Scientist, all the space junk crowding Earth's orbit makes it nearly impossible to determine if either of those explanations, or any other, is correct. (That problematic crowding of Earth's orbit, it's worth pointing out, was not a pressing issue during Relay 2's short life in the mid-1960s.) "In a world where there is a lot of space debris and there are more small, low-cost satellites with limited protection from electrostatic discharges, this radio detection may ultimately offer a new technique to evaluate electrostatic discharges in space" explained Aplin, who was not involved in the research. More on strange energy: Scientists Spot Mysterious Object in Our Galaxy Pulsing Every 44 Minutes
Bloomberg
14 hours ago
- Bloomberg
Regime Change Could Make Iran Even More Confrontational
Welcome back to The Forecast from Bloomberg Weekend, where we help you think about the future — from next week to next decade. We've tweaked our format just a tad! Let us know what you think by emailing: weekend@
Yahoo
a day ago
- Yahoo
Just 1 dose of magic mushroom compound eases depression for at least 5 years in most patients, small study suggests
When you buy through links on our articles, Future and its syndication partners may earn a commission. DENVER—Psilocybin, the main psychoactive ingredient in magic mushrooms, can alleviate depression for at least five years after a single dose, a new study finds. The research, presented June 18 at the Psychedelic Science 2025 conference in Denver, focused on patients with major depressive disorder (MDD), which is often called clinical depression. The serious mood disorder causes a persistent feeling of sadness and a loss of interest or pleasure in activities that were once enjoyable. The most common treatments for MDD include talk therapy and medications such as selective serotonin reuptake inhibitors, and both can take a long time to show any benefits. When early studies hinted at psilocybin's potential as an antidepressant, a team of researchers undertook the first-ever randomized clinical trial to explore the use of the psychedelic for treating severe depression. The trial included 24 patients, half of whom received psilocybin at the very start of the trial and half of whom received the same dose eight weeks later—the "waitlist" group. Each patient also received 11 hours of psychotherapy. Even in that short time frame, "there was a significant reduction in depression in the immediate-treatment group compared to those on the waitlist," study co-author Alan Davis, director of the Center for Psychedelic Drug Research and Education at The Ohio State University, told Live Science. Once all of the patients had completed the four-week study, the psilocybin appeared to be four times more effective than traditional antidepressant medications, based on previous research data. One month after the treatment, 17 patients had relieved symptoms, including 14 who were in full remission from depression. Patients also responded much faster to psilocybin than is typical for conventional antidepressants. But do these benefits of psilocybin last? Related: Magic mushrooms temporarily 'dissolve' brain network responsible for sense of self Very few long-term studies of psilocybin for depression have been conducted to date, said Dr. Charles Raison, a professor of human ecology and psychiatry at the University of Wisconsin-Madison who was not involved in the research. "They are very difficult to do because people drop out," Raison told Live Science in an email. "But also because they go on all sorts of other treatments that obfuscate the degree to which any longer lasting benefits result from the psychedelic or because the participant got therapy or restarted an antidepressant." To investigate whether the benefits for psilocybin lasted and if the patients had experienced any side effects, the researchers contacted the original trial participants several years later to request their enrollment in a follow-up study. Twenty-one patients enrolled, and their clinicians rated any changes in the participants' levels of depression from before the original treatment to the present day. The patients also filled out a series of self-reported, online questionnaires and met up with clinicians to document their ability to engage in everyday tasks, their levels of anxiety and their general mental health. The researchers assumed that the three patients that didn't sign up for the follow up, and the three that didn't complete the questionnaires had not remained in remission. Even so, the researchers found that 67% of the participants who had suffered from depression half a decade earlier remained in remission after a single psychedelic therapy session. These patients also reported less anxiety and less difficulty functioning on a daily basis. In general, the two-thirds of the patients who responded well reported lasting positive changes in their mindsets, emotional health and relationships. "I'm excited by these deeper aspects of their lives that really speaks to the importance of these interventions beyond just reduction of depression," Davis said. RELATED STORIES —Psychedelics rapidly change the brain. Here's how. —Australia clears legal use of MDMA and psilocybin to treat PTSD and depression —'Magic mushroom' treatment for depression inches closer to approval Most of the patients shared that, following the original treatment, they'd engaged in self-reflection and therapy to help understand themselves and navigate life's challenges. Davis hypothesizes that the psychedelic experience catalyzes a deeper therapy process and would like to conduct future studies comparing the relative influences of psilocybin and psychotherapy in alleviating depression. "The biggest caveat of this study is the small sample size, and the fact that the original trial showed larger antidepressant effects than subsequent larger multi-site studies seem to be showing," Raison said. In a multi-site clinical trial with 233 participants, 37% of the 79 who received a single 25 mg dose of psilocybin, coupled with psychotherapy, went into remission from major depression. While these trials report less widespread antidepressant effects, they support the idea that psilocybin can effectively treat depression, Davis said, and he is keen to see how the findings of multi-site trials hold up five years post-treatment.
